The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.
about
Characterization of PET/CT images using texture analysis: the past, the present… any future?Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.Stage-directed individualized therapy in esophageal cancer.Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer.Editorial on "Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer".FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.Radiomics and radiogenomics for precision radiotherapy.Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.Radiomics: the bridge between medical imaging and personalized medicine.Effect of tube current on computed tomography radiomic features.Endoscopic and Imaging Predictors of Complete Pathologic Response After Chemoradiation for Esophageal Cancer.Guidelines and Experience Using Imaging Biomarker Explorer (IBEX) for Radiomics.Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy.Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy
P2860
Q30837034-104A90EB-BBEA-4862-870A-06A56878B756Q36304217-789A8D58-7375-42F0-9C37-20D9FA434D92Q38888100-A0E0A5F1-9928-4BEA-84DA-16A1C5BA57DEQ45946420-330DA6A7-F2AC-4709-889D-47BA4582C18AQ47120642-E9C7DC13-4F8A-4D8B-8CAA-F049CF57BB72Q47642688-55707759-9CE3-41EA-A403-02438102CCFBQ47701839-8ED6D5E8-FE0C-4CE0-8835-60020A9B28F0Q47784630-93893793-CA1D-46B0-8A50-EBE4BC8BF74AQ47869134-B814CEB5-F32B-4317-95D0-FBCCE8C64299Q48102678-55C81DF8-1C6F-49AA-A33E-5846A2718CF7Q49566998-8C95D322-481C-4836-95CD-8A0E6FCD4162Q49826440-D9579EAB-4BC9-4312-AF23-BD72E9C7896CQ52581750-09493F9D-8D52-43A7-B880-CFA1B25E2745Q55437617-192143FF-0FB3-45DD-9997-4A00E8959FB9Q56993545-F3B53645-74F8-4229-82C5-480E15A26480
P2860
The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@ast
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@en
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@nl
type
label
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@ast
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@en
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@nl
prefLabel
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@ast
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@en
The Incremental Value of Subje ...... otherapy in Esophageal Cancer.
@nl
P2093
P1476
The Incremental Value of Subje ...... iotherapy in Esophageal Cancer
@en
P2093
David V Fried
Gert J Meijer
Lifei Zhang
Marco van Vulpen
Peter S N van Rossum
Steven H Lin
Wayne L Hofstetter
P304
P356
10.2967/JNUMED.115.163766
P407
P577
2016-01-21T00:00:00Z